UltraQuant Assay SARS-CoV-2 Quantification V1 (RUO)

REF 162A

Description

The UltraQuant Assay SARS-CoV-2 Quantification V1 (RUO) is a  real time RT-PCR test  intended to quantification of  SARS-CoV-2 genome  using extracted RNA from already diagnosed positive patients to SARSCoV-2.

 

Methodology

Reverse Transcriptase Polymerase Chain Reaction (RT-PCR).

The test targets the N gene of the SARS-CoV-2, including regions that harbor mutations of interest described as sufficient, when present to identify variants of concern (VOC).

Intended user

The product  is intended to be used by trained clinical laboratory personnel specifically instructed and trained in the techniques of RT-PCR .

Complementary information

More information on Ultragene Assays – Click here

Intended Use (RUO)

The UltraQuant Assay SARS-CoV-2 Quantification V1 is a  RT-PCR test amplifying the N gene of the SARS-CoV-2 for Quantification .

 

 

Characteristics and performances

Features

For Reasearch Use Only (RUO)

RealTime PCR thermocyclers Compatibility:

Any qPCR instrument compatible with the FAM and Cy5 channels. Validated for Use with:
- QuantStudio 5 Real Time PCR Instrument
- UltraGene qPCR 48 Instrument

Format / Models

- 50 tests/kit (162A50)
- 1000 tests/kit 162A1000

Content

- RT-PCR Premix
- Primers/Probe Mix
- Positive Control
- Negative Control
- Internal Reference Control (IRC)
- Molecular Grade Water

Hands-on-time

20 min

Estimated turnaround time

1h20

Analytical sensitivity (Limit of Detection (LoD))

100 copies/rx

Ordering information

Product

Reference

GTIN

UltraQuant Assay SARS-CoV-2 Quantification V1 (50 tests) (RUO)

162A50

UltraQuant Assay SARS-CoV-2 Quantification V1 (1000 tests) (RUO)

162A1000

Downloads

General Documentation

  • 162A Leaflet

    EN

    V1

Request Documentation

Email address
Assay Serial Number